US2002086370A1PendingUtilityA1
Method of producing l-lysine
Priority: Jun 7, 1995Filed: Jun 5, 1996Published: Jul 4, 2002
Est. expiryJun 7, 2015(expired)· nominal 20-yr term from priority
Inventors:Seiko OtsunaMasakazu SugimotoMasako IzuiAtsushi HayakawaEiichi NakanoMasaki KobayashiYasuhiko YoshiharaTsuyoshi Nakamatsu
C12N 9/88C12P 13/08C12N 15/52C12N 9/1217C12N 9/0016C12N 15/77C12N 1/20
28
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The L-lysine-producing ability and the L-lysine-producing speed are improved in a coryneform bacterium harboring an aspartokinase in which feedback inhibition by L-lysine and L-threonine is substantially desensitized, by successively enhancing DNA coding for a dihydrodipicolinate reductase, DNA coding for a dihydrodipicolinate synthase, DNA coding for a diaminopimelate decarboxylase, and DNA coding for a diaminopimelate dehydrogenase.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A recombinant DNA autonomously replicable in cells of coryneform bacteria, comprising a DNA sequence coding for an aspartokinase in which feedback inhibition by L-lysine and L-threonine is substantially desensitized, and a DNA sequence coding for a dihydrodipicolinate reductase.
2 . The recombinant DNA according to claim 1 , further comprising a DNA sequence coding for a dihydrodipicolinate synthase.
3 . The recombinant DNA according to claim 2 , further comprising a DNA sequence coding for a diaminopimelate decarboxylase.
4 . The recombinant DNA according to claim 3 , further comprising a DNA sequence coding for a diaminopimelate dehydrogenase.
5 . The recombinant DNA according to any one of claims 1 to 4 , wherein said aspartokinase in which feedback inhibition by L-lysine and L-threonine is substantially desensitized is an aspartokinase originating from coryneform bacteria, and wherein said aspartokinase is provided as a mutant aspartokinase in which a 279th alanine residue as counted from its N-terminal is changed into an amino acid residue other than alanine and other than acidic amino acid in its α-subunit, and a 30th alanine residue is changed into an amino acid residue other than alanine and other than acidic amino acid in its β-subunit.
6 . The recombinant DNA according to any one of claims 1 to 4 , wherein said DNA sequence coding for the dihydrodipicolinate reductase codes for an amino acid sequence depicted in SEQ ID NO: 15 in Sequence Listing, or an amino acid sequence substantially the same as the amino acid sequence depicted in SEQ ID NO: 15.
7 . The recombinant DNA according to claim 2 , wherein said DNA sequence coding for the dihydrodipicolinate synthase codes for an amino acid sequence depicted in SEQ ID NO: 11 in Sequence Listing, or an amino acid sequence substantially the same as the amino acid sequence depicted in SEQ ID NO: 11.
8 . The recombinant DNA according to claim 3 , wherein said DNA sequence coding for the diaminopimelate decarboxylase codes for an amino acid sequence depicted in SEQ ID NO: 19 in Sequence Listing, or an amino acid sequence substantially the same as the amino acid sequence depicted in SEQ ID NO: 19.
9 . The recombinant DNA according to claim 4 , wherein said DNA sequence coding for the diaminopimelate dehydrogenase codes for an amino acid sequence depicted in SEQ ID NO: 24 in Sequence Listing, or an amino acid sequence substantially the same as the amino acid sequence depicted in SEQ ID NO: 24.
10 . A coryneform bacterium harboring an aspartokinase in which feedback inhibition by L-lysine and L-threonine is substantially desensitized, and comprising an enhanced DNA sequence coding for a dihydrodipicolinate reductase.
11 . The coryneform bacterium according to claim 10 , transformed by introduction of the recombinant DNA as defined in claim 1 .
12 . The coryneform bacterium according to claim 10 , further comprising an enhanced DNA sequence coding for a dihydrodipicolinate synthase.
13 . The coryneform bacterium according to claim 12 , transformed by introduction of the recombinant DNA as defined in claim 2 .
14 . The coryneform bacterium according to claim 12 , further comprising an enhanced DNA sequence coding for a diaminopimelate decarboxylase.
15 . The coryneform bacterium according to claim 14 , transformed by introduction of the recombinant DNA as defined in claim 3 .
16 . The coryneform bacterium according to claim 14 , further comprising an enhanced DNA sequence coding for a diaminopimelate dehydrogenase.
17 . The coryneform bacterium according to claim 16 , transformed by introduction of the recombinant DNA as defined in claim 4 .
18 . A method for producing L-lysine comprising the steps of cultivating said coryneform bacterium as defined in any one of claims 10 to 17 in an appropriate medium, producing and accumulating L-lysine in a culture of the bacterium, and collecting L-lysine from the culture.Join the waitlist — get patent alerts
Track US2002086370A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.